NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Summary

To learn if psilocybin can help to prevent or decrease the severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients who are receiving chemotherapy for the treatment of breast, colorectal, and In this study, psilocybin is being compared to standard supportive care and to a placebo.

Timeline

Start

2026-11-04

Primary completion

2029-01-31

Completion

2031-01-31

Drugs

Indications